UPC Case Law
Petition for review of a decision of the Registrar (EPLC Rules, Rule 12.1), anonymised applicant
Decision of the UPC Court of Appeal of 26 January 2026, UPC CFI 1/2023
UPC Case Law by Pitch, edited by Bart Lieben · Published
TL;DR
The President of the UPC Court of Appeal upheld the Registrar's refusal to enter a European Patent Attorney on the list of UPC representatives, because he relied on a Rule 12.1 EPLC Rules course but applied in August 2025, after the one-year transitional period had expired on 3 June 2024. The listed courses no longer count as a qualification under Art 48(2) UPCA. The time limit is not discriminatory, so the remaining routes are the European Patent Litigation Certificate or a Rule 11 EPLC Rules law diploma.
Key holding
Under Rule 12.1 EPLC Rules, the courses and certificates listed in Rule 12.1(a) count as an appropriate qualification for a European Patent Attorney under Art 48(2) UPCA only if the request for registration was filed within one year of the UPCA's entry into force, that is, by 3 June 2024. Rule 12 sets no time limit for filing a request, so a later request is admissible, but it is unfounded on the merits. As an exception to the accredited-course rule, Rule 12.1 cannot be extended beyond its wording. The one-year limit violates neither equal treatment nor proportionality.
Questions decided
- When did the Rule 12.1 EPLC Rules transitional period start and end?
- Is the one-year period an admissibility time limit or a substantive condition?
- Can Rule 12.1 EPLC Rules be applied beyond its literal wording?
- Is the one-year limit discriminatory because the UPCA has not entered into force in all signatory states?
- Is the limit discriminatory compared with Rule 11 EPLC Rules qualifications?
Full summary
Read the full analyses for free — create a free account
With a free Academy account you read the full analysis of every Court of Appeal decision: the facts and procedure, the issues, the court’s reasoning and the practice points. Your name, an e-mail address and a password; no payment, and you can delete the account yourself at any time.
In the same case
- Decision · UPC CoA 528/2024
Amgen, Inc v Sanofi-Aventis Deutschland GmbH and others
The Court of Appeal overturned the Munich central division and upheld Amgen's PCSK9 antibody patent EP 3 666 797 against Sanofi and Regeneron, finding that the skilled person had no reasonable expectation of success that an antibody would be therapeutically effective.
- Order · UPC CoA 826/2024
Microsoft Corporation v Suinno Mobile & AI Technologies Licensing Oy
The Court of Appeal's standing judge refused to review a Central Division order that let a patentee unconditionally cut the damages it claims from Microsoft.
- Order · UPC CoA 86/2024
Panasonic Holdings Corporation v Xiaomi Technology Germany GmbH and others
A claimant at the UPC cannot serve a statement of claim on Chinese and Hong Kong defendants simply by delivering it to their German group company.
More on infringement and claim interpretation
- Order · UPC CoA 145/2026
Barco N.V. v Yealink (Xiamen) Network Technology Co., Ltd. and others
The Court of Appeal upheld the Brussels Local Division's refusal to let Barco add a late auxiliary request (AR6) whose claim 1 is identical to dependent claim 9, a claim neither asserted for infringement nor attacked in the counterclaim for revocation.
- Decision · UPC CoA 678/2025
Hurom Co., Ltd. v NUC Electronics Co., Ltd and others
The Court of Appeal upheld the Paris Local Division's revocation of Hurom's juicer patent EP 3 155 936 (as amended) for lack of inventive step, refused Hurom's new auxiliary requests filed only on appeal, and confirmed dismissal of all infringement claims, including those for Poland.
- Decision · UPC CoA 908/2025
Hartmann Packaging A/S v Omni-Pac Ekco GmbH Verpackungsmittel and others
The Court of Appeal rejected Hartmann's infringement and revocation appeals on its egg-package patent EP 2 755 901.